Live Status Check

NCT05642455 Recruiting Status

Real-time enrollment status for this i cannot determine the primary condition from the provided information. the only condition listed is "genetic:afamitresgene autoleucel" which appears to be a treatment designation rather than a medical condition, and there are no keywords or meaningful summary details provided to identify what condition this pediatric study is actually treating. clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 8:48 AM UTC

NCT05642455 Status Summary

NCT NumberNCT05642455
Recruiting StatusRecruiting
ConditionI cannot determine the primary condition from the provided information. The only condition listed is "GENETIC:Afamitresgene autoleucel" which appears to be a treatment designation rather than a medical condition, and there are no keywords or meaningful summary details provided to identify what condition this pediatric study is actually treating.
PhaseClinical Trial
Target Enrollment20 participants
Active Locations10 sites in the US
SponsorAdaptimmune
Last Updated on CT.govFebruary 9, 2026 (3 weeks ago)

About NCT05642455 Enrollment Status

As of March 2, 2026: Clinical trial NCT05642455 is currently recruiting participants. This clinical trial study for i cannot determine the primary condition from the provided information. the only condition listed is "genetic:afamitresgene autoleucel" which appears to be a treatment designation rather than a medical condition, and there are no keywords or meaningful summary details provided to identify what condition this pediatric study is actually treating. is actively seeking new participants at 10 locations across the United States. The study is sponsored by Adaptimmune. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT05642455

Is NCT05642455 still recruiting?

Yes, NCT05642455 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT05642455 recruiting?

This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT05642455?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT05642455 status last updated?

The official ClinicalTrials.gov record for NCT05642455 was last updated 3 weeks ago (February 9, 2026). HelloStudys verifies this status automatically.

Browse More I cannot determine the primary condition from the provided information. The only condition listed is "GENETIC:Afamitresgene autoleucel" which appears to be a treatment designation rather than a medical condition, and there are no keywords or meaningful summary details provided to identify what condition this pediatric study is actually treating. Trials

Ready to Apply?

Check your eligibility for this clinical trial